Sabra Healthcare REIT (SBRA)
(Delayed Data from NSDQ)
$18.41 USD
+0.23 (1.27%)
Updated Aug 6, 2025 04:00 PM ET
After-Market: $18.39 -0.02 (-0.11%) 7:58 PM ET
2-Buy of 5 2
C Value C Growth D Momentum D VGM
Fundamental Charts
About Market Cap
As of the previous market close, Sabra Healthcare REIT, Inc. has a market cap of $4.36B, which represents its share price of $18.18 multiplied by its outstanding shares number of 239.79M. As a mid-cap company, SBRA's shareholders are generally exposed to less risk than shareholders of small-cap companies but more risk than large-cap companies.
The company's Market Capitalization is a measurement of company size. It is calculation of the company's share price times the number of outstanding shares. Large market cap companies give stability and are good long-term investments. Small market cap companies can produce faster growth and bigger returns, but their stockholders are exposed to more risk.
SBRA 18.41 +0.23(1.27%)
Will SBRA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for SBRA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for SBRA
Sabra (SBRA) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
Sabra Healthcare (SBRA) Q2 FFO and Revenues Surpass Estimates
SBRA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Should WisdomTree U.S. SmallCap Dividend ETF (DES) Be on Your Investing Radar?
Is WisdomTree U.S. SmallCap Dividend ETF (DES) a Strong ETF Right Now?
Sabra (SBRA) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
Other News for SBRA
SBRA Analyst Maintains Rating and Raises Price Target to $22 | SBRA Stock News
Janus Henderson U.S. Real Estate ETF Q2 2025 Commentary
Sabra Health Care (SBRA) Price Target Uplifted to $22 by Citizens JMP
Sabra Health Care price target raised by $2 at Citizens JMP, here's why
NAV Monitor: U.S. REITs Close July At Median 20.3% Discount To Net Asset Value